Our impact
Our skills have been instrumental in driving positive change across a diverse range of policy domains, such as Aboriginal health, healthy ageing, prevention, and beyond.
We recognise the importance of harnessing evidence from research to effectively address real-world challenges. While using research evidence may initially seem complex, we are committed to supporting our clients through this challenge.
Through collaborative efforts and strategic partnerships, we can accelerate the integration of research findings into practical solutions. The impact of our work is measurable and significant, and it demonstrates our steadfast determination to improve health and wellbeing through evidence-based approaches.
Examples of our impact:
- Funding for lung cancer screening: Data from the 45 and Up Study has informed important research on lung cancer and the cost-effectiveness of screening, which contributed to the federal government’s landmark decision to fund the National Lung Cancer Screening Program.
- Supporting COVID-19 management: We used a sophisticated simulation model to project patient numbers and resource needs at major intensive care units in NSW, helping decision-makers manage hospital and health-system resources.
- Understanding food insecurity in Aboriginal communities: We partnered with Aboriginal communities in NSW to produce the first quantitative data on the prevalence and severity of food insecurity, which is guiding policy decisions to tackle this key issue.
- Enhancing support for victims of domestic and family violence (DFV): Our evaluation of a pilot initiative that supported GPs and primary care staff to identify and assist victim-survivors of DFV resulted in the federal government investing $36.8 million to expand the initiative nationally.
Case Studies
“We are dedicated to driving transformative change in health and wellbeing. We strive to accelerate progress through sustainable partnerships and delivering measurable impact, ensuring a healthier and more equitable future for all Australians.”
Dr Martin McNamara, CEO, Sax Institute